To The Moon: Our Interview With ResearchSat
Recently, I had the chance to sit down and chat with ResearchSat’s founder/CEO RaviTeja Duggineni and their head of investor relations, Rahul Kundnani.
The Might of Mesoblast: How Perseverance Paid Off
Last year, Mesoblast Ltd had their therapeutic RYONCIL approved by the FDA. This article touches on the journey to get to this milestone.
Here’s why last week’s stock market crash is a warning sign for Australia’s biotech sector
Investments in biotechnology are most impactful when made by those with deep pockets. The aim of the game is to make a return on investment, which can only occur when biotech companies can create a profitable product. Without funding from angel investors/venture capitalists, many biotech companies cannot continue to meaningfully function. Analysis of the recent …
FightMND’s Beanie to Cure Pipeline: Where does the money go?
Who are FightMND? FightMND are a charity co-founded by Neale Daniher, Pat Cunningham and Dr Ian Davis. The charity aims to raise money to fund important clinical research so that treatments or a cure for MND may be discovered. Since 2014, more than $80 million dollars have been raised by the charity. Much of this …
Read more “FightMND’s Beanie to Cure Pipeline: Where does the money go?”
Everything you need to know about CRISPR
CRISPR is the future of gene editing in both medicine and agriculture. This article outlines everything you need to know about it!
Jumar and its Exciting Impact on Melbourne’s Biotech Sphere
Read this article to discover more about the newest addition to Melbourne’s biotech hub, Jumar Bioincubator! We discuss who the major players and winners are in the development of Jumar.
OPINION: Cultivated Meat has an Overreliance on Positive Coverage
Cultivated meat, grown from animal cells in controlled spaces, faces mixed public reception and media scrutiny, crucial for mainstream acceptance and success.
Big day for Aussie biotech: NSB and MSB soar
Two Australian stock exchange listed biotech companies, Neuroscientific Biopharmaceuticals LTD and Mesoblast LTD, have experienced upward spikes in share price as a result of positive news released over the Easter holiday.
Oh, Canada: Exopharm acquire Tryp Therapeutics
In a move known as a reverse merger, Exopharm Ltd have acquired Canadian biotech company Tryp Therapeutics, who will occupy Exopharm’s place on the ASX.
Understanding the Drug Development Pipeline
In this article: Introduction The drug development pipeline (DDP) is, at its core, the fundamental process that biopharma companies undergo in the quest to bring their therapeutic to market. It is composed of multiple stages that can be lumped into two groups: research and development. The research stages include everything from discovery of a potential …